搜索
市场行情
自选
新闻
分析
交易工具
选股器
扫码下载
一键诊股 让投资更聪明
English
繁体中文
ไทย
Tiếng việt
简体中文
Español
Português
Deutsch
한국어
日本語
登录
免费注册
搜索
免费注册
市场行情
/
股票
/
医药与医学研究
/
生物技术与医疗研究
/
galt
/
财务摘要
Galectin Therapeutics Inc
GALT
添加自选
3.960
USD
-0.090
-2.22%
收盘 09-24 16:00(美东)
260.81M
总市值
亏损
市盈率 TTM
Galectin Therapeutics Inc
3.960
-0.090
-2.22%
概览
新闻分析
财务
股票评分
技术分析
预测
持股情况
股息
公司资料
财务摘要
利润表
资产负债表
现金流量表
财报
公司估值
风险评估
概览
新闻分析
财务
股票评分
技术分析
预测
持股情况
股息
公司资料
财务摘要
利润表
资产负债表
现金流量表
财报
公司估值
风险评估
GALT 财务数据
通过专为投资者打造的一站式数据看板,全面查看 Galectin Therapeutics Inc 的财务状况。平台将复杂的财务报表整理为可自定义的视图,助您更轻松地进行财务分析。您可以查看最新年度财务报告,也可以通过利润表、资产负债表和现金流量表,按季度分析公司表现。借助实时财务指标,持续追踪公司的经营状况和市场表现更加便捷。
关键财务比率
总市值
260.81M
股息TTM
0.00
市盈率 TTM
-9.66
每股收益TTM
-0.41
营业收入
--
净利润
-47.20M
净资产收益率
0.00%
总资产收益率
-207.62%
Galectin Therapeutics Inc 财报日历
最新发布
8月 14, 2026
每股收益 / 预测值
-0.14
/-0.09
营业收入 / 预测值
--
/0.00
财务报表摘要
单季报
单季报+年报
单季报
年报
YOY
隐藏空白行
FY2026Q2
FY2026Q1
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q4
FY2021Q3
财务指标
每股收益
-16.52%
-0.14
49.31%
-0.08
55.19%
-0.09
29.03%
-0.13
40.18%
-0.12
18.08%
-0.15
-17.90%
-0.19
23.27%
-0.18
-29.73%
-0.20
4.28%
-0.19
9.69%
-0.16
--
-0.24
--
-0.15
--
-0.19
--
-0.18
--
--
--
--
--
--
--
--
--
--
净利润
-20.98%
-9.18M
47.25%
-5.07M
53.77%
-5.56M
26.83%
-8.22M
39.01%
-7.58M
16.46%
-9.61M
-19.58%
-12.03M
19.96%
-11.24M
-35.50%
-12.44M
0.26%
-11.50M
5.97%
-10.06M
-63.63%
-14.04M
5.17%
-9.18M
-16.25%
-11.53M
-46.80%
-10.70M
-0.28%
-8.58M
-13.66%
-9.68M
-56.40%
-9.92M
7.94%
-7.29M
-43.69%
-8.56M
资产负债率
20.30%
928.79%
155.68%
861.16%
12.77%
684.70%
163.37%
950.45%
128.55%
772.07%
5.74%
336.81%
138.67%
607.18%
30.82%
360.88%
12.39%
337.81%
28.99%
318.51%
35.96%
254.40%
--
275.87%
--
300.58%
--
246.93%
--
187.12%
--
--
--
--
--
--
--
--
--
--
利润表
营业利润
13.90%
-3.98M
48.37%
-4.08M
72.92%
-3.37M
53.70%
-4.20M
59.04%
-4.63M
18.15%
-7.90M
-29.99%
-12.43M
1.09%
-9.07M
-25.41%
-11.29M
6.71%
-9.65M
10.08%
-9.56M
-12.85%
-9.17M
6.82%
-9.00M
-4.10%
-10.34M
-43.21%
-10.63M
1.48%
-8.12M
-17.93%
-9.66M
-57.27%
-9.94M
5.20%
-7.42M
-39.12%
-8.24M
净利润
-20.98%
-9.18M
47.25%
-5.07M
53.77%
-5.56M
26.83%
-8.22M
39.01%
-7.58M
16.46%
-9.61M
-19.58%
-12.03M
19.96%
-11.24M
-35.50%
-12.44M
0.26%
-11.50M
5.97%
-10.06M
-63.63%
-14.04M
5.17%
-9.18M
-16.25%
-11.53M
-46.80%
-10.70M
-0.28%
-8.58M
-13.66%
-9.68M
-56.40%
-9.92M
7.94%
-7.29M
-43.69%
-8.56M
资产负债表
流动资产
-4.98%
14.66M
68.99%
15.69M
12.66%
19.44M
-55.60%
12.73M
-43.46%
15.43M
-63.53%
9.29M
-37.74%
17.25M
32.65%
28.67M
40.16%
27.29M
30.22%
25.46M
34.83%
27.71M
26.23%
21.61M
-24.50%
19.47M
-41.65%
19.55M
-50.86%
20.55M
-54.94%
17.12M
-22.65%
25.79M
47.00%
33.51M
41.93%
41.82M
12.14%
38.00M
流动负债总额
1307.27%
151.62M
-93.41%
7.31M
-77.32%
8.03M
440.21%
136.44M
-26.29%
10.77M
777.38%
110.84M
125.88%
35.41M
140.05%
25.26M
46.86%
14.62M
9.54%
12.63M
20.47%
15.68M
9.74%
10.52M
-8.62%
9.95M
20.95%
11.53M
44.05%
13.01M
15.53%
9.59M
79.91%
10.89M
104.48%
9.54M
67.31%
9.03M
233.56%
8.30M
总资产
-4.97%
14.83M
65.40%
15.76M
11.64%
19.53M
-55.60%
12.87M
-43.58%
15.60M
-63.20%
9.53M
-37.96%
17.50M
30.72%
28.97M
37.72%
27.66M
28.01%
25.89M
32.49%
28.20M
23.72%
22.16M
-22.43%
20.08M
-39.83%
20.23M
-49.11%
21.29M
-52.90%
17.91M
-22.51%
25.89M
46.81%
33.62M
41.31%
41.83M
11.72%
38.04M
总负债
14.24%
151.68M
19.88%
146.00M
20.87%
145.73M
12.34%
136.44M
20.92%
132.77M
25.59%
121.79M
36.32%
120.56M
66.29%
121.45M
54.20%
109.80M
54.25%
96.98M
65.38%
88.44M
81.46%
73.04M
73.22%
71.21M
57.94%
62.87M
36.39%
53.48M
39.81%
40.25M
152.37%
41.11M
753.70%
39.81M
625.19%
39.21M
1048.34%
28.79M
总权益
-16.80%
-136.85M
-16.01%
-130.24M
-22.44%
-126.19M
-33.63%
-123.58M
-42.63%
-117.17M
-57.92%
-112.26M
-71.10%
-103.07M
-81.79%
-92.48M
-60.67%
-82.15M
-66.69%
-71.09M
-87.12%
-60.24M
-127.77%
-50.87M
-235.85%
-51.13M
-588.62%
-42.65M
-1330.66%
-32.19M
-341.49%
-22.34M
-188.94%
-15.22M
-133.96%
-6.19M
-89.19%
2.62M
-70.68%
9.25M
现金流量表
经营净额
63.06%
-2.44M
49.72%
-3.87M
52.76%
-6.04M
58.51%
-3.54M
20.77%
-6.60M
36.48%
-7.69M
-172.03%
-12.79M
-11.80%
-8.54M
15.25%
-8.33M
-12.16%
-12.11M
35.05%
-4.70M
8.51%
-7.64M
-32.38%
-9.83M
-34.21%
-10.79M
-4.14%
-7.24M
-67.01%
-8.35M
-24.28%
-7.43M
-26.01%
-8.04M
-28.39%
-6.95M
39.14%
-5.00M
融资净额
-87.66%
1.60M
--
257.00K
1337.96%
12.24M
-87.04%
1.30M
24.73%
12.94M
-100.00%
0.00
-91.49%
851.00K
-0.33%
10.00M
3.76%
10.38M
0.00%
10.00M
0.00%
10.00M
--
10.03M
--
10.00M
--
10.00M
0.01%
10.00M
-100.00%
0.00
-100.00%
0.00
--
0.00
--
10.00M
--
10.00M
常见问题
Galectin Therapeutics Inc的流动资产是多少?
根据Galectin Therapeutics Inc的FY2025财报,流动资产为19.44M(同比变化12.66)。
Galectin Therapeutics Inc的总资产是多少?
根据Galectin Therapeutics Inc的FY2025财报,Galectin Therapeutics Inc的总资产为19.53M(同比变化11.64)。
Galectin Therapeutics Inc的总负债是多少?
根据Galectin Therapeutics Inc的FY2025财报,Galectin Therapeutics Inc的总负债为145.73M(同比变化20.87)。
Galectin Therapeutics Inc的总权益是多少?
根据Galectin Therapeutics Inc的FY2025财报,Galectin Therapeutics Inc的总权益为-126.19M(同比变化-22.44)。
Galectin Therapeutics Inc的净营业收入是多少?
根据Galectin Therapeutics Inc的FY2025财报,Galectin Therapeutics Inc的净营业收入为-20.09M(同比变化52.67)。
Galectin Therapeutics Inc的净融资是多少?
根据Galectin Therapeutics Inc的FY2025财报,Galectin Therapeutics Inc的净融资为26.48M(同比变化-15.22)。
Galectin Therapeutics Inc的每股收益(EPS)是多少?
根据Galectin Therapeutics Inc的FY2025财报,每股收益(EPS)为-0.48(同比变化36.01)。
Galectin Therapeutics Inc的净利润是多少?
根据Galectin Therapeutics Inc的FY2025财报,净利润为-30.97M(同比变化34.38)。
Galectin Therapeutics Inc的债务与资产比率是多少?
根据Galectin Therapeutics Inc的FY2025财报,债务与资产比率为684.70(同比变化12.77)。
Galectin Therapeutics Inc的资产回报率(ROA)是多少?
根据Galectin Therapeutics Inc的FY2025财报,资产回报率(ROA)为-166.56(同比变化19.11)。
Galectin Therapeutics Inc的营业利润是多少?
根据Galectin Therapeutics Inc的FY2025财报,营业利润为-20.09M(同比变化52.67)。